{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:54:28Z","timestamp":1790373268254,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.cll.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T17:10:48Z","timestamp":1443373848000},"page":"765-778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinical Manifestations and Treatment of Lyme Disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Joyce L.","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2015.08.004_bib1","unstructured":"C.f.D.C.a.P. Reported cases of Lyme disease by year, United States, 1995\u20132013. 2015. Available at: http:\/\/www.cdc.gov\/lyme\/stats\/chartstables\/casesbyyear.html. Accessed September 16, 2015."},{"issue":"4","key":"10.1016\/j.cll.2015.08.004_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/376914","article-title":"Asymptomatic infection with Borrelia burgdorferi","volume":"37","author":"Steere","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2015.08.004_bib3","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"2725","article-title":"Lyme disease (Lyme Borreliosis) due to Borrelia burgdorferi","author":"Steere","year":"2015"},{"issue":"5","key":"10.1016\/j.cll.2015.08.004_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(95)99915-9","article-title":"The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans","volume":"100","author":"Nadelman","year":"1996","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.cll.2015.08.004_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-130-1-199901050-00006","article-title":"Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia","volume":"130","author":"Strle","year":"1999","journal-title":"Ann Intern Med"},{"issue":"24","key":"10.1016\/j.cll.2015.08.004_bib6","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","article-title":"The presenting manifestations of Lyme disease and the outcomes of treatment","volume":"348","author":"Steere","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2015.08.004_bib7","first-page":"684","article-title":"Lyme disease","volume":"371","author":"Shapiro","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2015.08.004_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.35.1.47","article-title":"The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis","volume":"35","author":"Pachner","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.cll.2015.08.004_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cll.2015.07.002","article-title":"Nervous system lyme disease","author":"Halperin","year":"2015","journal-title":"Clin Lab Med"},{"issue":"5","key":"10.1016\/j.cll.2015.08.004_bib10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/MAO.0b013e31827c9f93","article-title":"Lyme disease associated with sudden sensorineural hearing loss: case report and literature review","volume":"34","author":"Peeters","year":"2013","journal-title":"Otol Neurotol"},{"issue":"2","key":"10.1016\/j.cll.2015.08.004_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.idc.2007.12.008","article-title":"Lyme carditis","volume":"22","author":"Fish","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.cll.2015.08.004_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","article-title":"The clinical evolution of Lyme arthritis","volume":"107","author":"Steere","year":"1987","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cll.2015.08.004_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20052471","article-title":"Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide","volume":"203","author":"Steere","year":"2006","journal-title":"J\u00a0Exp Med"},{"issue":"9396","key":"10.1016\/j.cll.2015.08.004_bib14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","article-title":"Lyme borreliosis","volume":"362","author":"Stanek","year":"2003","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.cll.2015.08.004_bib15","first-page":"253","article-title":"Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients","volume":"263","author":"Asbrink","year":"1986","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"issue":"14","key":"10.1016\/j.cll.2015.08.004_bib16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A\u00a0critical appraisal of \u201cchronic Lyme disease\u201d","volume":"357","author":"Feder","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cll.2015.08.004_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cll.2015.08.004_bib18","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cll.2015.08.004_bib19","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease: do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.cll.2015.08.004_bib20","first-page":"189","article-title":"Human fetal borreliosis, toxemia of pregnancy, and fetal death","volume":"263","author":"MacDonald","year":"1986","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"issue":"24","key":"10.1016\/j.cll.2015.08.004_bib21","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1001\/jama.1986.03370240064038","article-title":"Lyme disease during pregnancy","volume":"255","author":"Markowitz","year":"1986","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.cll.2015.08.004_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/0003-4819-103-1-67","article-title":"Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi","volume":"103","author":"Schlesinger","year":"1985","journal-title":"Ann Intern Med"},{"issue":"22\u201323","key":"10.1016\/j.cll.2015.08.004_bib23","first-page":"933","article-title":"Erythema migrans in pregnancy","volume":"111","author":"Maraspin","year":"1999","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.cll.2015.08.004_bib24","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1016\/j.ijid.2009.07.019","article-title":"Maternal Lyme borreliosis and pregnancy outcome","volume":"14","author":"Lakos","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"20","key":"10.1016\/j.cll.2015.08.004_bib25","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1114362","article-title":"Differentiation of reinfection from relapse in recurrent Lyme disease","volume":"367","author":"Nadelman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2015.08.004_bib26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432935","article-title":"Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions","volume":"41","author":"Wormser","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2015.08.004_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinids\/14.1.263","article-title":"Facial palsy and infection: the unfolding story","volume":"14","author":"Morgan","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.cll.2015.08.004_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.cll.2015.08.004_bib29","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/JCM.30.10.2692-2697.1992","article-title":"In\u00a0vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies","volume":"30","author":"Dever","year":"1992","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.cll.2015.08.004_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cll.2015.08.004_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199707313370501","article-title":"Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease","volume":"337","author":"Dattwyler","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2015.08.004_bib32","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.44.7.1203","article-title":"Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis","volume":"44","author":"Karlsson","year":"1994","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.cll.2015.08.004_bib33","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial","volume":"7","author":"Ljostad","year":"2008","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.cll.2015.08.004_bib34","first-page":"PI136","article-title":"Macrolide therapy of chronic Lyme disease","volume":"9","author":"Donta","year":"2003","journal-title":"Med Sci Monit"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2015.08.004_bib35","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/516171","article-title":"Tetracycline therapy for chronic Lyme disease","volume":"25","author":"Donta","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2015.08.004_bib36","first-page":"94","article-title":"Repeated antibiotic treatment in chronic Lyme disease","volume":"5","author":"Fallon","year":"1999","journal-title":"J Spirochetal Tick-Borne Dis"},{"issue":"1 Suppl 48","key":"10.1016\/j.cll.2015.08.004_bib37","first-page":"S12","article-title":"Bacterial triggers and autoimmune rheumatic diseases","volume":"26","author":"Girschick","year":"2008","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271215001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271215001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T21:54:58Z","timestamp":1599602098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271215001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0272271215001031"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2015.08.004","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Manifestations and Treatment of Lyme Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}